It has been a shaky time for healthcare stocks, but that only presents a buying opportunity. The Health Care Select Sector ...

Which healthcare stock can dividend investors safely buy? Let's consider two excellent options: AbbVie (NYSE: ABBV) and Amgen ...

The Amgen Irish Open has been confirmed in a September date at The K Club as part of the DP World Tour’s 2025 schedule.

Tezspire is currently approved for the treatment of severe asthma in the US, EU, Japan, and nearly 60 countries across the globe. It is approved as a single-use pre-filled syringe and auto-injector ...

TEZSPIRE demonstrated a statistically significant and clinically meaningful reduction in nasal polyp size and reduced nasal congestion compared to placebo ...

(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients ...

Vaccinex has global commercial and development rights to pepinemab and is the sponsor of the KEYNOTE-B84 study which is being performed in collaboration with Merck Sharp & Dohme Corp, a subsidiary of ...

In May 2024, Novartis announced new data that confirm the long-term efficacy and safety of remibrutinib, a highly selective ...

Background Pulmonary microvasculature alterations are implicated in emphysema pathogenesis, but the association between ...

While Am­gen didn’t re­veal much about up­com­ing read­outs for its high­ly-an­tic­i­pat­ed weight loss drugs dur­ing third-quar­ter earn­ings, the com­pa­ny did de­tail cer ...

Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off.

(RTTNews) - Amgen Inc. (AMGN) reported earnings for its third quarter that increased from the same period last year and beat the Street estimates. The company's bottom line came in at $2.83 ...